Biofarm S.A. (BVB:BIO)

Romania · Delayed Price · Currency is RON

1.240

-0.020 (-1.59%)

At close: Apr 28, 2026

82.89% (1Y)

Market Cap	1.22B +82.4%
Revenue (ttm)	319.33M +11.4%
Net Income	100.63M +35.3%
EPS	0.09 +34.3%
Shares Out	985.37M
PE Ratio	13.46
Forward PE	n/a
Dividend	0.04 (3.49%)
Ex-Dividend Date	May 13, 2026

Volume	98,683
Average Volume	44,998
Open	1.255
Previous Close	1.260
Day's Range	1.180 - 1.255
52-Week Range	0.632 - 1.355
Beta	0.52
RSI	46.39
Earnings Date	May 15, 2026

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, medical devices, and other products. The company also exports its products in Albania, ... [Read more]

Industry Pharmaceutical Preparations

Founded 1921

Employees 369

Stock Exchange Bucharest Stock Exchange

Ticker Symbol BIO

Full Company Profile

Financial Performance

In 2025, Biofarm's revenue was 319.33 million, an increase of 11.36% compared to the previous year's 286.77 million. Earnings were 100.63 million, an increase of 35.27%.

Financial Statements